Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HLTHCARE, and what generic and branded alternatives to HLTHCARE drugs are available?
HLTHCARE has three approved drugs.
Drugs and US Patents for Hlthcare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hlthcare | ATENOLOL | atenolol | TABLET;ORAL | 073026-002 | May 1, 1992 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hlthcare | ATENOLOL | atenolol | TABLET;ORAL | 073026-003 | Sep 17, 1991 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hlthcare | DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE;INJECTION | 200146-001 | Jul 18, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.